FDA device listing
Matrix Metalloproteinase-9 Test Kit (Colloidal Gold method)
FDA device listing 1051834107 · Zhide Mingchuang Biotechnology (Wuxi) Co., LTD.
Key facts
| Proprietary names | Matrix Metalloproteinase-9 Test Kit (Colloidal Gold method) |
|---|---|
| Owner/operator | Zhide Mingchuang Biotechnology (Wuxi) Co., LTD. |
| Owner/operator number | 10091571 |
| Product codes | PFQ |
| Device names | PFQ - Mmp-9 Test System |
| Device class | Class I |
| Classification regulations (21 CFR) | 862.1540 |
| Review panels | Clinical Chemistry |
| Registered establishments | ZHIDE MINGCHUANG BIOTECHNOLOGY (WUXI) CO., LTD. |
| Establishment registrations | 3026309985 |
| FEI numbers | 3026309985 |
| Establishment operations | Foreign Exporter, Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database